Yuno A, Kenmotsu Y, Takahashi Y, Nomoto H, Kameda H, Cho KY, Nakamura A, Yamashita Y, Nakamura J, Nakakubo S, Kamada K, Suzuki M, Sugino H, Inoshita N, Konno S, Miyoshi H, Atsumi T, Sawamura Y, Shimatsu A.
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Endocrine Journal, in press.
IF: 1.952 (2019)
Takahashi K, Nakamura A, Furusawa S, Yokozeki K, Sugawara H, Yanagisawa H, Akikawa K, Kikuchi H. Initial dip predicts renal protective effects after the administration of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease with normoalbuminuria.
J Clin Transl Endocrinol, 2020 (in press).
IF：なし
Amengual O, Atsumi T.
COVID-19 pandemic in Japan.
Rheumatology International. Accepted, October 29, 2020. In press DOI:
10.1007/s00296-020-04744-9
IF: 1.984
Suzuki K, Suda G, Yamamoto Y, Furuya K, Baba M, Nakamura A, Miyoshi H, Kimura M, Maehara O, Yamada R, Kitagataya T, Yamamoto K, Shigesawa T, Nakamura A, Ohara M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S and Sakamoto N for the NORTE Study Group.
Tenofovir disoproxil fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection. J Gastroenterol, in press.
IF: 6.132
Favorable effect of sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin on nonalcoholic fatty liver disease compared with pioglitazone.
Cho KY, Nakamura A, Omori K, Takase T, Miya A, Yamamoto K, Nomoto H, Kameda H, Taneda S, Kurihara Y, Aoki S, Atsumi T, Miyoshi H Journal of Diabetes Investigation, in press.
IF 3.761
Khatri S,Psaraftis N, Funaro A, Arinuma Y, Fujieda Y, Mader, S,Jørgensen CD and AstakhovaK.
Serological Comparison of Systemic Lupus Erythematosus with Neuropsychiatric Lupus using Synthetic Nucleic Acid Antigens Journal of Translational Autoimmunity
IF：なし
Miyoshi A, Kameda H, Nagai S, Nakamura A, Miya A, Takase T, Astumi T, Miyoshi H.
Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulator in postmenopausal women with type 2 diabetes and osteoporosis.
Journal of Diabetes Investigation, in press.
IF: 3.761
Klionsky DJ,,, Kato M,,, et al. (2345 coauthors) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Autophagy, in press.
IF：9.770
Naruse K, Abiko A, Nakayama H, Tanaka N, Ikeda K, Imachi H, Usigome E, Umayahara Y, Ota S, Okada Y, Kodani N, Takahashi N, Terai A, Nakamura A, Fujikawa R, Miura J, Morita E, Yanagimachi M, Ueki K on behalf of the Japan Diabetes Society Committee to Promote Female Diabetologists.
The work style and living condition survey of diabetologists and the expectations for the Japan Diabetes Society: results of questionnaires about the current state and the future prospect of their carrier in 2017.
Diabetol Int. 11:299–308, 2020
IF:なし
